Revolutionizing Pharmacovigilance: The Role of  Artificial Intelligence in Enhancing Patient Safety

Sachin Kumar; Prabhat Agarwal; Sachin Kumar

Sachin Kumar Assistant Professor, School of Allied Health Sciences and Management, Delhi Pharmaceutical Sciences and Research University, New Delhi, India
Prabhat Agarwal Assistant Professor, SGT College of Pharmacy, SGT University, Gurugram, Haryana, India
Sachin Kumar Assistant Professor, Department of Pharmacology, Delhi Pharmaceutical Sciences and Research University, New Delhi, India

Keywords: Adverse Drug Reactions, Artificial Intelligence, Pharmacovigilance

Abstract

Background: Pharmacovigilance (PV) is responsible for monitoring drug safety, and Artificial Intelligence (AI) is a promising technology that has the potential to transform this field.
Objective: This article will investigate the role of AI in PV and its potential benefits for patient safety and healthcare providers.
Methods: A structured review of relevant literature was conducted to identify studies that demonstrate the applications of AI in PV. The identified studies were analysed to determine the specific roles of AI in PV and its potential benefits.
Results: The practice of AI in PV allows for the analysis of large datasets, adverse event reporting, the detection of safety signals, the prioritisation of safety issues, data mining, and predictive modelling. The benefits of AI in PV include improved efficiency, increased accuracy, enhanced patient safety, faster analysis of safety issues related to drugs, and reduced healthcare costs.
Conclusion: AI has enormous potential to improve PV by streamlining case processing and improving the identification of adverse events. However, there are also challenges that need to be addressed in
implementing AI in PV. Overall, AI has significant promise for enhancing patient safety and reducing healthcare costs.

How to cite this article:
Kumar S, Agarwal P, Kumar S. Revolutionizing
Pharmacovigilance: The Role of Artificial
Intelligence in Enhancing Patient Safety. Chettinad
Health City Med J. 2025;14(2):78-86.

DOI: https://doi.org/10.24321/2278.2044.202527

References

Peters T, Soanes N, Abbas M, Ahmad J, Delumeau JC, Herrero-Martinez E, Paramananda M, Piper J, Smail-Aoudia F, van der Spuij W, Veizovic T. Effective pharmacovigilance system development: EFPIA-IPVG

consensus recommendations. Drug safety. 2021 Jan;44:17-28. [Google Scholar] [Pubmed]

Luo Y, Thompson WK, Herr TM, Zeng Z, Berendsen MA, Jonnalagadda SR, Carson MB, Starren J. Natural language processing for EHR-based pharmacovigilance: a structured review. Drug safety. 2017 Nov;40:107589. [Google Scholar]